J Invest Dermatol 133(2):565567
A recent AP-NORC poll showed that 61 percent believe it is a very or somewhat bad thing for adults to take GLP-1 agonists to lose weight, at least if they are not obese or suffering from a weight-related health condition
Hypoglycemia Risk in Type 2 Diabetes Patients Patients switching who also use insulin or a sulfonylurea face a higher hypoglycemia risk
Keep in mind their potential side effects GLP-1 agonists come with a long list of potential adverse effects such as: Digestive system: stomach pain, nausea, vomiting, constipation, diarrhea, heartburn, indigestion, flatulence, bloating, belching, and gastroesophageal reflux Nervous system: headache, dizziness, fatigue, mood changes, and suicidal behavior or ideation Low blood sugar and diabetic retinopathy in people with diabetes Allergic reactions Drug interactions Heart rate changes Gall stones Pancreatitis Kidney damage Increased risk of thyroid cancer According to cardiologist and MyFitnessPal scientific advisor Danielle Belardo, MD, most gut-related side effects can be resolved through dietary changes like eating smaller meals, increasing fiber intake, and staying hydrated
[DOI] [PMC free article] [PubMed] [Google Scholar] Ban TA, Wilson WH, and McEvoy JP (1980) Amoxapine: a review of literature
Individual responses vary based on genetics, diet, and exercise adherence
